PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference
September 18 2017 - 7:30AM
Business Wire
PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly
differentiated, multi-product medical device company, today
announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief
Executive Officer, will present at the Cantor Fitzgerald Global
Healthcare Conference on Wednesday, September 27, 2017 at 10:55
a.m. Eastern time. Dr. Aklog will provide a corporate overview,
discuss the Company’s innovative business model and review PAVmed’s
lead products. The conference is taking place at the
InterContinental New York Barclay Hotel in New York City on
September 25-27, 2017.
To access the live webcast of the presentation, please click
here. A replay will be available following the presentation.
About PAVmed Inc.
PAVmed Inc. (Nasdaq: PAVM, PAVMW) is a highly differentiated,
multi-product medical device company employing a unique business
model designed to advance products from concept to
commercialization much more rapidly and with significantly less
capital than the typical medical device company. This proprietary
model enables PAVmed to pursue an expanding multi-product pipeline
strategy with a view to enhancing and accelerating value creation.
PAVmed’s diversified pipeline of products address unmet clinical
needs, have attractive regulatory pathways and market opportunities
and encompass a broad spectrum of clinical areas including carpal
tunnel syndrome (CarpX™), medical infusions (NextFlo™ and
NextCath™), interventional radiology (PortIO™ and NextCath), tissue
ablation and cardiovascular intervention (Caldus™) and pediatric
ear infections (DisappEAR™).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170918005170/en/
InvestorsLHA Investor RelationsKim
Sutton Golodetz,
212-838-3777kgolodetz@lhai.comorinfo@pavmed.comorMediaRooney PartnersKate Barrette,
212-223-0561kbarrette@rooneyco.com
PAVmed (NASDAQ:PAVMW)
Historical Stock Chart
From Mar 2024 to Apr 2024
PAVmed (NASDAQ:PAVMW)
Historical Stock Chart
From Apr 2023 to Apr 2024